Chargement en cours...
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...
Enregistré dans:
| Publié dans: | Breast Cancer (Auckl) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Libertas Academica
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214808/ https://ncbi.nlm.nih.gov/pubmed/28096680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S12443 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|